Rtw Investments, LP Merus N.V. Transaction History
Rtw Investments, LP
- $6.51 Billion
- Q2 2025
A detailed history of Rtw Investments, LP transactions in Merus N.V. stock. As of the latest transaction made, Rtw Investments, LP holds 4,000,553 shares of MRUS stock, worth $255 Million. This represents 3.23% of its overall portfolio holdings.
Number of Shares
4,000,553
Previous 4,169,393
4.05%
Holding current value
$255 Million
Previous $175 Million
19.91%
% of portfolio
3.23%
Previous 2.88%
Shares
8 transactions
Others Institutions Holding MRUS
# of Institutions
217Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$273 Million10.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$238 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$225 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$216 Million4.09% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.16MShares$201 Million3.03% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.93B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...